https://www.selleckchem.com/pr....oducts/epertinib-hyd
Screening with Low-dose computed tomography (LDCT) of high-risk individuals with a smoking history reduces lung cancer mortality. Current screening guidelines and eligibility criteria can miss over 50% of lung cancers, and in some geographical areas, like East Asia, a large proportion of the missed lung cancers are in never-smokers. Although randomized trials demonstrated the benefits of screening for people who smoke, these trials generally excluded never-smokers. Thus, the feasibility and effectiveness of lung cancer s
Gefällt mir
Kommentar
Teilen
